COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Inhibitors of the Ras Superfamily G-proteins, Part B - 1st Edition - ISBN: 9780124201460, 9780124202115

Inhibitors of the Ras Superfamily G-proteins, Part B, Volume 34

1st Edition

0.0 star rating Write a review
Serial Volume Editors: Fuyuhiko Tamanoi Channing J. Der
Hardcover ISBN: 9780124201460
eBook ISBN: 9780124202115
Imprint: Academic Press
Published Date: 25th November 2013
Page Count: 280
Sales tax will be calculated at check-out Price includes VAT/GST
97.00
159.00
111.30
121.00
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

  • Preface
  • Chapter One. Discovery of Small-Molecule Ras Inhibitors that Display Antitumor Activity by Interfering with Ras·GTP–Effector Interaction
    • Abstract
    • 1 Introduction
    • 2 Discovery of Surface Pockets in Novel Crystal Structures of Ras·GTP
    • 3 Discovery of the Kobe0065-Family Compounds by In Silico Screening
    • 4 Inhibition of Ras Functions by the Kobe0065-Family Compounds
    • 5 Structural Basis for Inhibition of Ras Functions by the Kobe0065-Family Compounds
    • 6 Specificity of the Kobe0065-Family Compounds Toward Various Small GTPases
    • 7 Discussion and Conclusion
    • Acknowledgments
    • References
  • Chapter Two. An Orthosteric Inhibitor of the RAS–SOS Interaction
    • Abstract
    • 1 Introduction
    • 2 RAS Signaling in Normal Physiology and Malignancy
    • 3 Strategies for Targeting RAS Activity
    • 4 Inhibitor Design
    • 5 RAS Binding
    • 6 Cell Entry and Intracellular Effects
    • 7 Conclusions
    • References
  • Chapter Three. Conformation-Specific Inhibitors of Raf Kinases
    • Abstract
    • 1 Introduction
    • 2 Kinase Conformations and Different Types of Kinase Inhibitors
    • 3 Representative Raf Inhibitors and Their Binding Modes
    • 4 Raf Kinase Dimerization and Activation
    • 5 Perspective
    • 6 Conclusion
    • Acknowledgments
    • References
  • Chapter Four. Inhibitors of the ERK Mitogen-Activated Protein Kinase Cascade for Targeting RAS Mutant Cancers
    • Abstract
    • 1 Introduction
    • 2 Ras and the ERK MAPK Effector Signaling Network
    • 3 Role of the ERK MAPK Cascade in Mutant RAS-Dependent Tumor Progression and Maintenance
    • 4 MEK1/2 Inhibitors
    • 5 ERK1/2 Inhibitors
    • 6 Issues and Questions
    • Acknowledgments
    • References
  • Chapter Five. Inhibiting the RAS–PI3K Pathway in Cancer Therapy
    • Abstract
    • 1 Introduction
    • 2 The PI3K Pathway
    • 3 PI3K Inhibitors
    • 4 PI3K Pathway Inhibitors
    • 5 Inhibiting PI3K in Cancer
    • 6 Future Directions
    • References
  • Chapter Six. The RalGEF/Ral Pathway: Evaluating an Intervention Opportunity for Ras Cancers
    • Abstract
    • 1 Introduction
    • 2 RalGEF/Ral Signaling and Cancer: A Rationale for Pathway Inhibition
    • 3 Modes of RalGEF/Ral Pathway Inhibition
    • 4 Conclusion
    • Acknowledgments
    • References
  • Chapter Seven. p21-Activated Kinase Inhibitors
    • Abstract
    • 1 Introduction
    • 2 ATP-competitive PAK Inhibitors
    • 3 Allosteric PAK Inhibitors
    • 4 Conclusions and Outlook
    • References
  • Chapter Eight. Recent Progress in Developing Small Molecule Inhibitors Designed to Interfere with Ras Membrane Association: Toward Inhibiting K-Ras and N-Ras Functions
    • Abstract
    • 1 Introduction
    • 2 Combined Inhibition of FTase and GGTase-I to Inhibit K-Ras and N-Ras
    • 3 ICMT Inhibitors
    • 4 Inhibiting the Interaction of K-Ras and PDEδ
    • 5 Future Prospects
    • Acknowledgments
    • References
  • Chapter Nine. Synthetic Lethal Genetic Screens in Ras Mutant Cancers
    • Abstract
    • 1 Introduction
    • 2 Synthetic Lethality and Its Application in Cancer Research
    • 3 Synthetic Lethality Screen to Find “Achilles’ Heel” of Ras Mutant Cancers
    • 4 Conclusion and Perspectives
    • Acknowledgments
    • References
  • Author Index
  • Subject Index

Description

Targeted toward researchers in biochemistry, molecular and cell biology, pharmacology, and cancer, this is the second part of The Enzymes' volumes that discuss inhibitors of the Ras superfamily G-proteins.

Key Features

  • Informs and updates on all the latest developments in the field
  • Contributions from leading authorities and industry experts

Readership

Researchers in biochemistry, molecular and cell biology, pharmacology, and cancer


Details

No. of pages:
280
Language:
English
Copyright:
© Academic Press 2013
Published:
25th November 2013
Imprint:
Academic Press
Hardcover ISBN:
9780124201460
eBook ISBN:
9780124202115

Ratings and Reviews


About the Serial Volume Editors

Fuyuhiko Tamanoi

Affiliations and Expertise

Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, USA

Channing J. Der

Affiliations and Expertise

University of North Carolina at Chapel Hill, Chapel Hill, USA